Masimo Stock

Masimo EBIT

The EBIT of Masimo (MASI) as of Jul 7, 2026 is 312.8 T USD.In the previous year, EBIT was 63.5 T USD — a change of 392.6% (higher).

EBIT

312.8 TUSD

YoY

392.6%

Last updated:

In 2026, Masimo's EBIT was 312.8 T USD, a 392.6% increase from the 63.5 T USD EBIT recorded in the previous year.

The Masimo EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2006
46.4 base
Jan 1, 2007
68.4 base
Jan 1, 2008
72.1 base
Jan 1, 2009
82.5 base
Jan 1, 2010
90.2 base
Jan 1, 2011
101.2 base
Jan 1, 2012
85.2 base
Jan 1, 2013
87.7 base
Jan 1, 2014
93.2 base
Jan 1, 2015
100.7 base
Jan 1, 2016
165.9 base
Jan 1, 2017
183.8 base
Jan 1, 2018
208.4 base
Jan 1, 2019
221.2 base
Jan 1, 2020
255.3 base
YEAREBIT (M USD)
2029 est 593.54
2028 est 562.89
2027 est 503.44
2026 est 453.95
2025 312.8
2024 63.5
2023 183.8
2022 226.6
2021 275.8
2020 255.3
2019 221.2
2018 208.4
2017 183.8
2016 165.9
2015 100.7
2014 93.2
2013 87.7
2012 85.2
2011 101.2
2010 90.2
2009 82.5
2008 72.1
2007 68.4
2006 46.4
Access this data via the Eulerpool API

Masimo Revenue

Masimo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
224.3 M USD
46.4 M USD
61.8 M USD
Jan 1, 2007
256.3 M USD
68.4 M USD
23.1 M USD
Jan 1, 2008
307.1 M USD
72.1 M USD
31.9 M USD
Jan 1, 2009
349.1 M USD
82.5 M USD
53.2 M USD
Jan 1, 2010
405.4 M USD
90.2 M USD
73.5 M USD
Jan 1, 2011
439 M USD
101.2 M USD
63.7 M USD
Jan 1, 2012
493.2 M USD
85.2 M USD
62.3 M USD
Jan 1, 2013
547.2 M USD
87.7 M USD
58.4 M USD
Jan 1, 2014
586.6 M USD
93.2 M USD
72.5 M USD
Jan 1, 2015
630.1 M USD
100.7 M USD
83.3 M USD
Jan 1, 2016
712.9 M USD
165.9 M USD
311.1 M USD
Jan 1, 2017
790.2 M USD
183.8 M USD
124.8 M USD
Jan 1, 2018
858.3 M USD
208.4 M USD
193.5 M USD
Jan 1, 2019
937.8 M USD
221.2 M USD
196.2 M USD
Jan 1, 2020
1.14 B USD
255.3 M USD
240.3 M USD

Masimo Margins

Masimo stock margins

The Masimo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Masimo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Masimo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
72.54 %
20.69 %
27.55 %
Jan 1, 2007
71.28 %
26.69 %
9.01 %
Jan 1, 2008
70.86 %
23.48 %
10.39 %
Jan 1, 2009
71.27 %
23.63 %
15.24 %
Jan 1, 2010
70.45 %
22.25 %
18.13 %
Jan 1, 2011
66.99 %
23.05 %
14.51 %
Jan 1, 2012
66.16 %
17.27 %
12.63 %
Jan 1, 2013
65.57 %
16.03 %
10.67 %
Jan 1, 2014
66.62 %
15.89 %
12.36 %
Jan 1, 2015
65.07 %
15.98 %
13.22 %
Jan 1, 2016
67.09 %
23.27 %
43.64 %
Jan 1, 2017
66.06 %
23.26 %
15.79 %
Jan 1, 2018
66.98 %
24.28 %
22.54 %
Jan 1, 2019
67.09 %
23.59 %
20.92 %
Jan 1, 2020
64.97 %
22.32 %
21.01 %

Masimo Stock analysis

What does Masimo do? Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Masimo's EBIT

Masimo's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Masimo's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Masimo's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Masimo’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Masimo stock

EBIT of Masimo amounted to 63.5 T USD 312.8 T

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Masimo

All Key Metrics — Masimo